The trademark application QUILLIVANT was filed by Tris Pharma, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on February 11, 2021, and it was registered by office on May 21, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on February 1, 2021. Change of name and professional address of the trademark registration was recorded on February 10, 2021. Appointment and Replacement of representative of the trademark registration was recorded on November 24, 2021.